Marksans Pharma Goa facility undergoes successful inspection from German Health Authorities
Mumbai: Marksans Pharma Limited has recently announced that the Company's newly acquired Goa manufacturing facility has successfully undergone inspection from German health authorities.
"This is to inform you that Marksans Pharma's newly acquired manufacturing facility located at Plot No. A1, Phase 1-A, Verna Industrial Estate, Verna, Goa - 403722 has successfully undergone inspection from German health authorities," the Company informed in a BSE filing.
"The Authorities have not found any critical/major observations but have few recommendations/ minor points which the Company is committed to implement immediately," Marksans Pharma stated.
Medical Dialogues team had earlier reported that the USFDA had completed a Post-marketing Adverse Drug Experience (PADE) inspection.
Read also: Marksans Pharma gets 2 USFDA observations for Goa facility
Marksans Pharma Limited, headquartered in Mumbai, India, is engaged in Research, Manufacturing and marketing of generic pharmaceutical formulation in the global markets. The company's manufacturing facilities located in India, USA and UK are approved by several leading regulatory agencies including USFDA, UKMHRA and Australian TGA. The company's robust product portfolio spreads over major therapeutic segments of CVS, CNS, Antidiabetic, Pain Management, Gastroenterological and Anti-allergies. The company is marketing these products globally.
Read also: Marksans Pharma bags USFDA nod for Esomeprazole Magnesium Delayed Release Capsules
